Combined immune checkpoint inhibitors (ICIs) vs chemotherapy alone
Overall survival (OS) · People with advanced non‐small cell lung cancer
Combined immune checkpoint inhibitors (ICIs) probably leads to lower overall Survival (OS) compared with chemotherapy (moderate certainty).
1 finding from 1 review
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without… 2021 · Cochrane Headline outcomes onlyHR 0.72 [0.59, 0.89]2 studies · 612 participantsModerate